Get started

Gileadscience

GileadGILD- If you didn't hear the news, yesterday Gilead labs were accredited with a drug that has been positively treating COVID19 patients. I checked the price and it is very expensive already. I had a look at the chart today and noticed that the last time this stock crossed golden (50/200 MA) on the weekly, it skyrocketed. On top of that, it held support like a champ. That moment is about to happen yet again. It is high risk due to price, you have to allocate less shares to spare your capital and an appropriate stop loss is at the weekly 200 MA. You must be ok to lose about $12 a share if the trade goes south but I see a massive opportunity in the works.
NASDAQ:GILDLong
by LucyF2492
7
ridethepig | GILD 2019-nCoV TargetA good time to review the previous floor at 60.xx that we have been tracking for almost a year in $GILD. Here taking the latest misses in Q4 Earnings with a pinch of salt as the red carpet has been rolled out for Gild via China. Once again another buying opportunity given the latest progress around Phase III clinical trials: On the Remdesivir (GS-5734) side, this is their free pass into the Chinese Healthcare system. Models will need to start quickly repricing revenue from the Hep B cases in China. GILD will do the heavy lifting here, +/- $20 upside available on the headline for FDA approval which looks around the corner. Flow-wise, the initial target area from the latest technical break comes into play at 86.xx (+25% from current levels). As usual thanks for keeping the support coming with likes, comments and etc!
NASDAQ:GILDLong
by ridethepig
2
Gilead Sciences - hit 2014-04-10 support level. I don't have a position in this stock, but I am waiting patiently to enter with a medium-long term strategy. For the following reasons: 1. Appr. 50% reduction in price from all time high in USD$123 (june 2015) to USD$65 (feb 2017). 2. USD$65 is the previous support level from 2014-04-10. 3. The stock has gapped twice already 1# 2016-07-25 and 2# 2017-02-08. 4. Risk:Reward is 1:3.62 My strategy would be to enter USD$ 66-67, with a Stop-loss in $58 and first time target in $83 and wait for the possible retracement, and then pick up some more shares and next target in $97. I am no professional investor or investment advisor, but is doing this solely for the sport. Please comment if you disagree/agree.
NASDAQ:GILDLong
by Greendiamonds
Check out monthly chartCheck Monthly chart. GILD is one of the fastest growing company, but had to drop their share price since Hillary want to drop Drug price. She keep repeating since last year, but it will not really damage drug price. It will actually damage CVS or insurance companies. GILD rebate a lot of money to CVS and insurance companies. Plus, Chart is very attractive and valuation is very good compare to other companies. Buy at : 78~83 target price 1: 108 target price 2: 112 target price 3: 120+
NASDAQ:GILDLong
by STOCKOUS